Navigation Links
CNS Response Announces Fiscal Third Quarter 2007 Results
Date:8/19/2007

NS Response is also an aide to pharmaceutical developers, who can use rEEG(SM) to (1) stratify study populations to improve the success of FDA clinical trials; (2) provide insight on effective therapeutic dosing of investigational drugs; (3) identify additional indications for psychiatric medications; (4) provide insight into effective drug combinations; and (5) discover opportunities for decision analytics and support. In addition to these applications, CNS Response continues to investigate the use of rEEG analysis for development of proprietary pharmaceutical opportunities.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements involve risks and uncertainties as set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.

Contacts:

Investor Relations:

Sara Ephraim

(646) 536-7002

sephraim@theruthgroup.com

Media:

Janine McCargo / Jason Rando

(646) 536-7033 / 7025

jmccargo@theruthgroup.com

jrando@theruthgroup.com


'/>"/>
SOURCE CNS Response, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related biology technology :

1. Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system
2. FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses
3. IT critical in pandemic response, but many are not paying attention
4. Quick response manufacturing and biotech
5. Speaker announces business members of IT Task Force
6. Doyle announces technology tax credits for Berbee
7. Doyle announces new energy, global warming policies
8. Doyle announces $80M renewable energy strategy
9. GE announces first installation of Discovery VCT
10. UWM announces winners of RGI awards
11. Third Wave announces two senior management appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...China, Dec. 2 /PRNewswire-Asia-FirstCall/ -- Tiany...), a manufacturer and supplier,of modernized trad... China,today announced the implementation of a n...h distributors and hospital clients into three cla...ng structure. , The new strategy has classi...
(Date:12/2/2008)...to File NDA with FDA in Early to Mid-2009 , ,...all/ -- Strativa Pharmaceuticals, the proprietary ... Inc. (NYSE: PRX ) today announced that its deve...ul completion of all pivotal bioequivalence studie...ondansetron thin film product is being developed f...
(Date:12/2/2008)...H, Mich., Dec. 2 GeneGo, Inc., the...today that Burnham has become a certified GeneGo C... institution-wide access to GeneGo,s MetaCore data...he Burnham institute is a world-class biomedical r...al studies throughout many departments, including ...
(Date:12/2/2008)... CARMEL, Israel, December 2 InSigh...ow that Magnetic Resonance-guided Focused,Ultraso...otential to be an,effective noninvasive pain-reli...e bones (bone metastases). The results of a 31 pat... of Annals of Surgical Oncology, while data from a...
Breaking Biology Technology:Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 3New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 4
...in-based health care imaging software and services... PACS version 1.2.7. The new version features enh...on tools, image viewer plug-in and automated acces...d an electronic medical record makes provision of ...desktop highly desirable," said William Stafford, ...
...nology Council has published the first-ever magazi...-page publication highlights the states research b..., quality of life, key contacts and the I-Q Corrid...t. Paul. , ,The Wisconsin Technology Network has ...onsin The Smart Choice, over the next few weeks. ...
...an, president and CEO of the University of Wiscons...cal affairs for UW Medical School was the kick-off.... In this interview with WTN, Dr. Grossman discuss...lumes of data but, at the same time a Knowledge Ga...n is board certified in internal medicine, pulmona...
...nce Sept. 16-17 at the Monona Terrace on how games...aims to present successful projects in which games...s Initiative , the Academic Advanced Distributed ...ientists Learning Federation Project are co-spon...lity development of a new generation of game-based...
Other Biology Technology:Life Science: From Chicago to the Twin Cities: All tech roads lead to Wisconsin 2Life Science: From Chicago to the Twin Cities: All tech roads lead to Wisconsin 3WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 2WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 3WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 4WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 5
(Date:12/2/2008)...OUSTON, Dec. 2, 2008 Scientists and engineers fro... and energy will come together Dec. 8, along with...xplore synergies in moving oil and pumping blood. ... heart must pump blood through the body. Both sys...vessels), free of blockages or corrosion, to funct...
(Date:12/2/2008)...ew Haven, Conn.Organizations in the United States ...from climate change are not adapting enough to the...o a Yale report. , "Despite a half century of cl...ed temperature and precipitation patterns and has ... impacts, and despite a near certainty that the Un...
(Date:12/2/2008)...msterdam, 2 December 2008 - Elsevier is delighted ... be the official publisher of the quarterly peer-r...t ( www.elsevier.com/locate/esd ) on behalf of th...tainable development involves meeting present huma...ations. Energy is central to providing many of the...
(Date:12/2/2008)...erforming systematic reviews of nutrition related ...red in the field of medicine. In a new article, a ...ibe the steps, strengths, and limitations of syste...e factors that impact the results. , Systematic...ws, provide objective assessments with pre-specifi...
Breaking Biology News(10 mins):Using the other guy's toolkit: Similarities of pumping blood, oil examined 2Most US organizations not adapting to climate change 2Most US organizations not adapting to climate change 3New publishing partnership for Energy for Sustainable Development 2Experts discuss applying systematic review to the field of nutrition 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment of Moderate 1835 1Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment of Moderate 1835 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment of Moderate 1835 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment of Moderate 1835 4Compensation Risk Managers LLC Receives Notice of Administrative Action by New York Workers Compensation Board 17061 1Compensation Risk Managers LLC Receives Notice of Administrative Action by New York Workers Compensation Board 17061 2Compensation Risk Managers LLC Receives Notice of Administrative Action by New York Workers Compensation Board 17061 3ACS Systems Improving Delivery of Healthcare in Malta 17060 1ACS Systems Improving Delivery of Healthcare in Malta 17060 2ACS Systems Improving Delivery of Healthcare in Malta 17060 3Limited transparency in federal nanotech research may hamper development 4665 1Limited transparency in federal nanotech research may hamper development 4665 2
...ublished this week report findings that increase o... determined and how the speed of its development i...on the molecular and cellular pathways that act to...e, as well as on pathways that use that informatio...uring development. , The two studies are reported ...
...w ,dwarf belonging to the sea, in laboratoryScient...ir thinking about how Archaea, an ancient kingdom ...aintaining the global balance of nitrogen and carb... known to oxidize ammonia for energy and metaboliz...tively named, Nitrosopumilus maritimus, in the lab...
...w species, a team of international scientists leav... undiscovered treasures in the Mountains of Southw...ntain range. , "Expedition Everest: Mission Himal...ore one of the planet,s richest and most biologica...ith a month-long exploration in China where scient...
...irst medical uses of nanotechnology, a chemist and...diseases have joined forces to create an early det...most common cause of hospitalization among childre...sends about 120,000 children to the hospital in th...e-threatening in one case out of every 100, it inf...
Other Biology News:Hormones and growth: The control of body size and developmental growth rate in fruit flies 2Marine bacterium suspected to play role in global carbon and nitrogen cycles 2Team of international scientists departs today to discover the unknown in China's Himalayan region 2Team of international scientists departs today to discover the unknown in China's Himalayan region 3Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections 2Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections 3Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections 4
SAGE (serial analysis of gene expression) technology allows comprehensive genome-wide expression analysis. Expression profiles generated by SAGE are sensitive enough to detect low-abundance transcrip
Sheep Serum US Origin
...te in utility and flexibility press-to-seal silico...f the researcher. They are available either pre-cu...rial that can be easily trimmed to prepare customi...nd non-cytotoxic and can be used to isolate cells ...
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine.
Biology Products: